Raras
Buscar doenças, sintomas, genes...
Síndrome de paraplegia espástica-epilepsia-perturbação do desenvolvimento intelectual
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Paraplegia espástica hereditária (PEH) é um grupo de doenças hereditárias cuja principal característica é um distúrbio progressivo da marcha. A doença apresenta-se com rigidez progressiva (espasticidade) e contração nos membros inferiores. A PEH também é conhecida como paraparesia espástica hereditária, paraplegia espástica familiar, doença do assentamento francês, doença de Strumpell ou doença de Strumpell-Lorrain. Os sintomas resultam da disfunção de axônios longos na medula espinhal. As células afetadas são os neurônios motores primários; portanto, a doença é uma doença do neurônio motor superior. A PEH não é uma forma de paralisia cerebral, embora fisicamente possa parecer e se comportar de forma muito semelhante à diplegia espástica.

🏥
SUS: Cobertura parcialScore: 50%
PCDT disponívelCentros em: PA, PE, CE, DF, SP +5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa5
Últimos 10 anos200publicações
Pico202251 papers
Linha do tempo
2021Hoje · 2026📈 2022Ano de pico🧪 2023Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de paraplegia espástica-epilepsia-perturbação do desenvolvimento intelectual

Centros de Referência SUS

13 centros habilitados pelo SUS para Síndrome de paraplegia espástica-epilepsia-perturbação do desenvolvimento intelectual

Centros para Síndrome de paraplegia espástica-epilepsia-perturbação do desenvolvimento intelectual

Detalhes dos centros

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p.Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome).

Clinical genetics2026 Mar 20

Biallelic loss-of-function variants in FBXO31 cause autosomal-recessive intellectual disability. A recurrent de novo variant, c.1000G>A(p.Asp334Asn), has been described in association with an autosomal-dominant phenotype. To refine this phenotype and its clinical implications, we re-evaluated three published cases and ascertained four additional probands via advocacy networks, GeneMatcher, and clinician referral. Phenotyping included neurologic, behavioral, and dysmorphology assessment. All seven individuals carried the recurrent de novo FBXO31 p.Asp334Asn variant. A core neurodevelopmental profile was observed and included cerebral palsy (mixed hypotonia, spasticity, and dystonia), global developmental delay/intellectual disability, and speech impairment. Neuropsychiatric features were sometimes prominent and included attention-deficit/hyperactivity disorder, anxiety, stereotypies, autistic features, and behavioral dysregulation. Neuroimaging often showed a hypoplastic corpus callosum and posterior-predominant white-matter changes. In one individual, gray matter heterotopias were also observed. A subtle but consistent facial gestalt was noted. Recurrent FBXO31 p.Asp334Asn variants lead to a recognizable neurodevelopmental syndrome. Based on our findings, we recommend including FBXO31 in diagnostic algorithms for cerebral palsy and neurodevelopmental disorders. We propose the descriptive term "autosomal dominant FBXO31-associated neurodevelopmental disorder," and-consistent with the validating laboratory and with support from the FBXO31 Foundation-propose the eponym "Kruer syndrome."

#2

Multisystem manifestations of Sjögren-Larsson syndrome in early childhood and its dental implications.

BMJ case reports2026 Mar 13

Sjögren-Larsson syndrome (SLS) constitutes a rare genetic disorder manifesting as a complex neurocutaneous condition characterised by congenital ichthyosis, progressive neurological impairment and intellectual disability. This case report presents an early childhood female patient exhibiting the classic triad of symptoms, along with significant oral complications, including severe dental caries, enamel demineralisation and gingivitis. Molecular genetic testing confirmed a homozygous pathogenic variant in the ALDH3A2 (Aldehyde Dehydrogenase 3 family member 2) gene, establishing the diagnosis. The patient's management encompassed a comprehensive multidisciplinary approach, integrating dental interventions under general anaesthesia, systemic therapies for spasticity and cutaneous manifestations, and regular follow-up care. This case highlights the critical importance of recognising oral manifestations in SLS and emphasises the need for integrated oral healthcare within the broader therapeutic framework for affected individuals.

#3

CTNNB1-related disorders: clinical and radiological contributions from a French cohort.

Frontiers in neurology2026

CTNNB1 monoallelic pathogenic variants account for up to 4% of genetically determined cerebral palsy cases, yet their phenotypic spectrum remains poorly defined. We retrospectively analyzed 25 individuals with pathogenic CTNNB1 variants using medical records and a questionnaire. Data included genetic variants, perinatal history, developmental milestones, behavioral characteristics, head growth, feeding, sleep difficulties, neurological and ophthalmological assessments. Brain MRIs were reviewed by expert neuroradiologists. Twenty-two distinct heterozygous variants were identified. Microcephaly occurred in 16/22 patients. All exhibited global developmental delay, independent walking was achieved at a mean age of 2.1 years, with regression in 4/16 independent walkers. Behavioral disorders were frequent, as were oral sensorimotor disorders (21/25) and sleep disturbances (13/21). Lower limb hypertonia was present in 22/25 patients [spastic (8) and/or dystonic (11)]. Unstable gait were common among ambulatory patients. Exaggerated startle reactions, often since birth, were reported in 16/21. Exudative vitreoretinopathy was identified in 3/5 patients with retinal angiography. Brain MRI (19 patients) showed: thickening of anterior commissure (8), frontal lobe hypoplasia (9), widening of superior vermian sulci (10) and corpus callosum anomalies (7). This study broadens the spectrum of CTNNB1-related syndrome, reporting a complex motor phenotype combining (i) gait disturbances related to dystonic or non-dystonic hypertonia and unsteadiness, sometimes associated to dystonia in other body parts (ii) possible deterioration of motor achievements over the course of the disease (iii) an exaggerated startle reflex. New non-specific brain anomalies are precisely described. Our work underscores the need for registries and longitudinal studies to refine characterization and guide future therapies. PTS-related tetrahydrobiopterin deficiency (PTPSD) results in a lack of tetrahydropterin, an important cofactor for phenylalanine hydroxylase (PAH), tyrosine hydroxylase, and tryptophan hydroxylase. Deficiency can thus lead to neurotransmitter and neuropsychiatric disorders. The clinical spectrum of PTPSD is broad and differs according to age of onset, severity of disease, and whether preventative therapies were initiated and maintained from an early age. In the severe form, clinical symptoms may become apparent in the neonatal period and can include hypotonia, movement disorders, abnormal eye movements, autonomic dysregulation, and impaired development. Without treatment, developmental delays become more marked. Neurologic symptoms (dysarthria, dystonia, tremors, abnormal gait, parkinsonism, oculogyric crises, motor tics) may be ameliorated by treatment with sapropterin dihydrochloride and neurotransmitter precursors. Other features of the condition can include psychiatric comorbidities (ADHD, anxiety, depression), infant feeding difficulties leading to early growth failure, hyperprolactinemia, growth hormone deficiency, sleep issues, and autonomic dysfunction; many of these features can be ameliorated by appropriate treatment. In treated individuals, development often improves during adolescence, with many adults having a normal IQ level. In the mild (peripheral) form, affected individuals are usually asymptomatic apart from an increase in phenylalanine (Phe) levels. Some remain asymptomatic. However, with time, some have mild developmental delays and can develop deficiency of neurotransmitter production, such that treatment of some asymptomatic individuals may be required. The biochemical diagnosis of PTPSD is established in a proband with confirmed hyperphenylalaninemia, elevated neopterin levels, reduced biopterin levels, and a decreased biopterin-to-neopterin ratio in urine or dried blood spots (DBS) and normal dihydropteridine reductase (DHPR) activity in DBS. The molecular diagnosis of PTPSD is established in a proband by identification of biallelic pathogenic (or likely pathogenic) variants in PTS by molecular genetic testing. Targeted therapies: Immediate therapy with sapropterin (tetrahydrobiopterin dihydrochloride; BH4), a cofactor/cosubstrate of PAH, is recommended to reduce blood Phe concentrations in individuals with hyperphenylalaninemia. If sapropterin is not available, dietary Phe restriction should be implemented. Because sapropterin has limited access to the central nervous system (CNS), or rather, this access is only achieved at high doses, therapy with sapropterin does not normalize the activity of tyrosine or tryptophan hydroxylase in people with PTPSD. Additional treatment strategies are necessary for long-term management and may include the use of neurotransmitter precursors (levodopa plus decarboxylase inhibitor (DCI), i.e., carbidopa or benserazide), 5-hydroxytryptophan, and/or dopamine (rotigotine patch, pramipexole) and/or serotonin agonists, or other medications (MAO inhibitors such as selegiline) to address specific neurotransmitter deficiencies and maintain optimal neurologic function. Supportive care: Optimization of dosage and intervals of levodopa/DCI in those with abnormal movements/parkinsonism; growth hormone supplementation and/or optimization of neurotransmitter precursor therapy for growth hormone deficiency; optimization of neurotransmitter precursor therapy for recurrent hyperthermia; anticholinergic treatment may be considered for hypersalivation; standard treatment for developmental delay, spasticity, epilepsy, sleep disorders, and decreased bone mineral density. Biochemical surveillance: Routine Phe monitoring in infants (age <1 year) weekly until normalized and then every three to six months once levels normalize; every six months in children younger than age 12 years; and every six to 12 months in adolescents and adults; the Phe target ranges correspond to those of PAH deficiency. Prolactin level at each visit. Routine clinical visits with a metabolic specialist (and metabolic dietician if on Phe-restricted diet) every one to three months in infants (age <1 year), every three to six months between ages one and seven years, and every six to 12 months in those age eight years and older. General surveillance: At each visit, measure growth parameters and evaluate nutritional status; asses for new neurologic manifestations (changes in tone, seizures, movement disorders); monitor developmental progress and assess educational needs; monitor for behavioral issues (anxiety, ADHD, emotional dysregulation, depression, aggression); and assess for signs and symptoms of sleep disorders. At ages two, six, 12, and 18 years, consider neuropsychological evaluation. In adulthood, periodic parathormone levels and DXA scan. As needed, consider EEG to differentiate from movement disorder seizures. Agents/circumstances to avoid: Persons with PTPSD on Phe-reduced diet should either avoid products containing aspartame or calculate total intake of Phe when using such products and adapt diet components accordingly. Evaluation of relatives at risk: If prenatal genetic testing has not been performed, each at-risk newborn sib should be evaluated immediately (at or just after 24 hours) after birth for PTPSD using measurement of blood Phe concentration to allow for earliest possible diagnosis and treatment. If older sibs have not undergone NBS or genetic testing for the known familial pathogenic variants in PTS, measure blood Phe concentrations to clarify their disease status. Pregnancy management: Women with PTPSD who have received appropriate treatment throughout childhood and adolescence and during pregnancy may have offspring with normal intellectual and behavioral development, particularly if levels of Phe are kept in the normal range during pregnancy. Intensive clinical and biochemical supervision by a multidisciplinary team before, during, and after pregnancy in a woman with PTPSD is essential to control the symptoms of the disease, adjust the treatment if needed, and monitor the development of the fetus. If the affected woman has elevated blood Phe concentrations during pregnancy, the fetus is at high risk for maternal phenylketonuria (MPKU) syndrome (reported specifically in women who have PAH deficiency as the primary cause of their elevated Phe levels), including malformations and intellectual disability, since Phe is a potent teratogen. PTPSD is inherited in an autosomal recessive manner. If both parents are known to be heterozygous for a PTS pathogenic variant, each sib of an affected individual has at conception a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of inheriting neither of the familial PTS pathogenic variants. Children born of one parent with PTPSD and one parent with two normal PTS alleles are obligate heterozygotes. If the mother is the affected parent, MPKU syndrome is a critical issue. Females with PTPSD should receive counseling regarding the teratogenic effects of elevated maternal plasma Phe concentration (i.e., MPKU syndrome) when they reach childbearing age. Once the PTS pathogenic variants have been identified in an affected family member, carrier testing for at-risk relatives and prenatal/preimplantation genetic testing for PTPSD are possible.

#4

Neuroradiological Phenotype Expansion of the Siddiqi Syndrome: A Case Report.

Cellular and molecular neurobiology2026 Feb 27

Siddiqi syndrome is a rare autosomal recessive deafness-dystonia disorder caused by pathogenic variants in the FITM2 gene. To date, only 5 unrelated families have been reported in the literature carrying loss-of-function variants in FIMT2 gene. In this report, we describe a 29-year-old woman with compound heterozygous novel variants identified by trio-based exome sequencing. She carries the paternally inherited delins variant c.158_161delinsTCAT, p.(Arg53_Asn54delinsLeuIle) and the maternally inherited frameshift variant c.567del, p.(Thr190ProfsTer9) in FITM2 gene. The patient exhibits the main features of the disease, including deafness, intellectual disability, regression of motor skills and poor overall growth. Additionally, she presents with spastic paraplegia which supports recent phenotypic expansion. We describe for the first time, novel brain magnetic resonance imaging signal alterations, not previously associated with this disorder. These neuroimaging findings may provide new insights into the neurological manifestations of Siddiqi syndrome. This case expands the phenotypic and molecular spectrum of FITM2 associated disease and emphasizes the adult-features of this syndrome. [Image: see text]

#5

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

American journal of human genetics2026 Mar 05

Disruption of the complex processes underlying central nervous system development leads to a broad spectrum of brain malformations and neurodevelopmental disorders, often with a genetic cause. Here, we report bi-allelic pathogenic variants in fibronectin type III and SPRY domain-containing 1-like (FSD1L), encoding a protein of unknown function, in eleven individuals, including five fetuses from six unrelated families. The phenotype ranges from severe hydrocephalus, corpus callosum agenesis, and absent pyramid decussation to a neurodevelopmental syndrome characterized by severe intellectual disability, spastic tetraparesis, reduced vision, and epilepsy, associated with corpus callosum agenesis/hypoplasia, mild ventricular dilation, optic nerve hypoplasia, and white matter reduction. This phenotype closely resembles that observed in L1 syndrome, caused by pathogenic variants in L1CAM, encoding a neural adhesion molecule. The knockdown of Fsd1l in mouse embryos recapitulated the ventricular dilation observed in affected fetuses. Immunohistochemical studies in human control fetuses revealed that FSD1L localized to neurons with commissural fate and projection neurons during human development. Induced pluripotent stem cell (iPSC)-derived neural progenitor cells from affected individuals failed to differentiate into premature neurons and to properly form neurospheres while undergoing increased cell death. In neural progenitors, FSD1L localized with microtubules of the mitotic spindle during M phase and to the transition zone and along the axoneme of the primary cilium during interphase. In line with this, fibroblasts from affected individuals exhibited marked alterations of the mitotic spindle and reduced ciliogenesis and ciliary length compared to control cells. Our findings define FSD1L as a microtubule-associated protein implicated in neuronal differentiation, axon guidance, and fasciculation.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p.Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome).

Clinical genetics
2026

Multisystem manifestations of Sjögren-Larsson syndrome in early childhood and its dental implications.

BMJ case reports
2026

CTNNB1-related disorders: clinical and radiological contributions from a French cohort.

Frontiers in neurology
2026

Neuroradiological Phenotype Expansion of the Siddiqi Syndrome: A Case Report.

Cellular and molecular neurobiology
2026

Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.

American journal of human genetics
2026

Morbidity and Mortality Among People Living With HTLV-1: A 30-Year Retrospective Analysis in a Brazilian Cohort.

Journal of medical virology
2026

Pain in multiple sclerosis: clinical phenotypes and therapeutic strategies - a narrative review.

Pain reports
2026

Expanding the clinical and immunological phenotypes of COPB1 deficiency.

Frontiers in immunology
2026

Early Recognition and Intervention for Poststroke Spasticity: A Scientific Statement From the American Heart Association.

Stroke
2025

Coffin-Lowry syndrome: a systematic review of RPS6KA3 confirmed cases and implications for diagnosis and counseling.

Frontiers in genetics
2026

Expanding the neurological spectrum of HTLV-1 beyond HAM/TSP: a contemporary perspective.

Lancet regional health. Americas
2026

Biallelic TTBK1 variant causes a severe syndromic neurodevelopmental disorder: clinical and genetic insights from two siblings.

Journal of medical genetics
2026

A proof-of-concept study on the effectiveness of botulinum toxin on spasticity plus syndrome in multiple sclerosis.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Lennox-Gastaut syndrome: Comorbidities and clinical implications.

Seminars in pediatric neurology
2025

Deciphering Spastic Ataxia: Clinical and Genetic Profiles.

Neurology. Genetics
2025

Neurodegeneration With Brain Iron Accumulation and Ferroptosis Disorders in Children and Adults: An Imaging Review.

Journal of neuroimaging : official journal of the American Society of Neuroimaging
2025

Leukoencephalopathy, brain calcifications, and cysts (LCC): Two unique cases.

Rare (Amsterdam, Netherlands)
2025

Two Chinese patients with Basilicata-Akhtar syndrome caused by novel MSL3 variants: a case report and literature review.

Translational pediatrics
2026

Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency.

Movement disorders : official journal of the Movement Disorder Society
2025

The first description of CTNNB1 syndrome in the Tunisian population: clinical investigation, molecular docking and molecular dynamics simulation of β-catenin/E-cadherin complex.

Molecular biology reports
2025

ATP6AP2-Related Disease Caused by Splicing Defects: Abnormal Glycosylation and the First Affected Female.

Journal of inherited metabolic disease
2025

Bi-allelic variants in the ribosomal protein RPS6KC1 cause a complex neurodevelopmental disorder.

American journal of human genetics
2025

Selective peripheral neurotomy for multifocal spasticity: Two-dimensional operative video.

Surgical neurology international
2025

Biallelic NDUFA9 variants cause a progressive neurodevelopmental disorder with prominent dystonia and mitochondrial complex I deficiency.

Brain communications
2025

Peripheral neuromodulation in spasticity-plus syndrome: effects of pulsed radiofrequency on tonic-painful disorders in multiple sclerosis.

Frontiers in neurology
2025

Dupilumab Reduces Pruritus in Twins With Sjögren-Larsson Syndrome.

Pediatric dermatology
2025

Kohlschütter-Tönz Syndrome: A Rare Clinical Entity with Amelogenesis Imperfecta in Two Siblings, Dental Management and Scoping Review.

Turkish archives of pediatrics
2025

The efficacy and safety of the ketogenic diet in infantile epileptic spasm syndrome: a meta-analysis.

Seizure
2025

A Case of Infantile Epileptic Spasms Syndrome with the SPTBN1 Mutation and Review of βII-Spectrin Variants.

Genes
2025

Case report of paroxysmal dystonia in a child with KBG syndrome: Expansion of the phenotype and utility of whole exome sequencing.

Medicine
2025

Maternal uniparental isodisomy in a patient with autosomal recessive spastic paraplegia type 20.

Gene
2025

Gait abnormalities in children with FOXP1 syndrome: A case series.

Journal of pediatric rehabilitation medicine
2025

Genome Sequencing Uncovers Additional Findings in Phelan-McDermid Syndrome.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2025

A Report of a Child with SEC31A-Related Neurodevelopmental Disorder.

International journal of molecular sciences
2025

French guidelines for the diagnosis and management of pure hereditary spastic paraplegia.

Revue neurologique
2025

French protocol for diagnosis and management of type 1 interferonopathies.

La Revue de medecine interne
2025

Further Delineation of the AUTS2 HX Repeat Domain-Related Phenotype.

American journal of medical genetics. Part A
2025

Expanding the spectrum of ATP8A2 mutations: a new splicing variant and systematic review of CAMRQ4 syndrome.

Molecular biology reports
2025

Arginase 1 deficiency: a treatable form of spastic paraplegia.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
2025

Sensory Dysfunction in ALS and Other Motor Neuron Diseases: Clinical Relevance, Histopathology, Neurophysiology, and Insights from Neuroimaging.

Biomedicines
2025

The implications of hyperekplexia on children's quality of life: a report on two cases.

Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo
2025

Identification of a novel non-coding deletion in Allan-Herndon-Dudley syndrome by long-read HiFi genome sequencing.

BMC medical genomics
2025

De Novo Deletion in the 12q24.23q24.31 Chromosomal Region Causing a Neurodevelopmental Syndrome in a Female Saudi Patient: A Case Report.

Cureus
2025

Outpatient Management of Clinical Comorbidities in Children With Cerebral Palsy in Low- and Middle-Income Countries.

Child: care, health and development
2025

Adult Leigh Syndrome Associated with the m.15635T>C Mitochondrial DNA Variant Affecting the Cytochrome b (MT-CYB) Gene.

International journal of molecular sciences
2025

Kidins220-deficient hydrocephalus mice exhibit altered glial phenotypes and AQP4 differential regulation in the retina and optic nerve, with preserved retinal ganglion cell survival.

Fluids and barriers of the CNS
2025

Ambulatory children with spastic cerebral palsy have smaller bone area and deficits in trabecular microarchitecture.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
2025

Worsening spasticity due to catheter breakage during intrathecal baclofen therapy: a case report.

Journal of medical case reports
2025

Intrathecal Baclofen Pump Wean and Risk of Exposure in a Large Total Body Surface Area Burn Wound Patient: A Case Report.

Journal of burn care &amp; research : official publication of the American Burn Association
2025

Sciatic nerve analysis in thyroid hormone transporters Mct8 and Oatp1c1 knockout mice.

European thyroid journal
2025

Cerebrotendinous xanthomatosis: A complex interplay between a clinically and genetically heterogeneous condition.

European journal of neurology
2025

From spastic paraplegia to infantile neurodegenerative disorder: Expanding the phenotypic spectrum associated with biallelic SPAST variants.

European journal of neurology
2025

CHD3-related Snijders Blok-Campeau syndrome with Spastic Paraplegia, Ataxia, and Situs Inversus.

European journal of medical genetics
2024

[Current state of algology - pain medicine - in the Russian Federation].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
2025

Accumulation of ether phospholipids in induced pluripotent stem cells and oligodendrocyte-lineage cells established from patients with Sjögren-Larsson syndrome.

Congenital anomalies
2024

Cervical myelopathy mistaken for complex regional pain syndrome: A case report.

Medicine
2025

New Insights Into TRMT10A Syndrome: Case Report and Literature Review.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2024

Synaptic dynamics linked to widespread elevation of H-reflex before peripheral denervation in amyotrophic lateral sclerosis.

Journal of neurophysiology
2024

Particularities of spasticity in myelomeningocele patients.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
2024

Prenatal Diagnosis of a KIDINS220 De Novo Heterozygous Variant in a Fetus With a Complex CNS Anomaly.

Prenatal diagnosis
2024

Atlantoaxial Instability due to Os Odontoideum in a Child with Christianson Syndrome.

Molecular syndromology
2024

The L1CAM SAX-7 is an antagonistic modulator of Erk Signaling.

bioRxiv : the preprint server for biology
2024

A Novel KIDINS220 Pathogenic Variant Associated with the Syndromic Spastic Paraplegia SINO: An Expansion of the Brain Malformation Spectrum and a Literature Review.

Genes
2024

Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia.

Journal of clinical immunology
2024

Novel autosomal recessive SINO syndrome-associated KIDINS220 variants provide insight into the genotype-phenotype correlation.

Heliyon
2024

Combined generalized and focal epilepsy with reflex features in Adaptor protein complex 4-associated hereditary spastic paraplegias: A cohort observational study.

Seizure
2024

A case report of spastic diplegic cerebral palsy in a late preterm child with hypoplastic left heart syndrome.

Translational pediatrics
2025

Successful Electroconvulsive Therapy in Aicardi-Goutières Syndrome Presenting Psychiatric Symptoms: An Unprecedented Clinical Case.

The journal of ECT
2024

Pure Hereditary Spastic Paraplegia in a Patient With a Novel Heterozygous KIDINS220 Gene Mutation.

Cureus
2024

A novel missense variant in the ATPase domain of ATP8A2 and review of phenotypic variability of ATP8A2-related disorders caused by missense changes.

Neurogenetics
2024

Refining the phenotype of SINO syndrome: A comprehensive cohort report of 14 novel cases.

Genetics in medicine : official journal of the American College of Medical Genetics
2024

The Effectiveness of Combining Botulinum Toxin Type A and Therapeutic Exercise in Treating Spasticity in a Patient with Complicated Stiff-Person Syndrome: A Case Report.

Diseases (Basel, Switzerland)
2024

De novo and inherited monoallelic variants in TUBA4A cause ataxia and spasticity.

Brain : a journal of neurology
2024

[Intrathecal baclofen therapy: a 30-year experience].

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
2024

Expanding the phenotype of Harel-Yoon syndrome: A case report suggesting a genotype/phenotype correlation.

American journal of medical genetics. Part A
2024

A Missense Variant in HACE1 Is Associated with Intellectual Disability, Epilepsy, Spasticity, and Psychomotor Impairment in a Pakistani Kindred.

Genes
2024

Electroacupuncture stimulation modulates functional brain connectivity in the treatment of pediatric cerebral palsy: a case report.

Frontiers in psychiatry
2024

A novel AP1S2 variant causing leaky splicing in X-linked intellectual disability: Further delineation and intrafamilial variability.

American journal of medical genetics. Part A
2024

An Ultra-Rare Mixed Phenotype with Combined AP-4 and ERF Mutations: The First Report in a Pediatric Patient and a Literature Review.

Genes
2024

Utilizing combination intrathecal baclofen and analgesic medication to manage spasticity and pain in patients with pediatric-onset disability: Case series.

Journal of pediatric rehabilitation medicine
2024

Single Nucleotide Polymorphism in Cell Adhesion Molecule L1 Affects Learning and Memory in a Mouse Model of Traumatic Brain Injury.

International journal of molecular sciences
2024

Pediatric Spastic Wrist Contractures Can Be Well Managed With Wrist Arthrodesis.

Journal of pediatric orthopedics
2024

Type 1 early infantile epileptic encephalopathy: A case report and literature review.

Molecular genetics &amp; genomic medicine
2024

Alterations in KIDINS220/ARMS Expression Impact Sensory Processing and Social Behavior in Adult Mice.

International journal of molecular sciences
2024

Flexor Pronator Slide Under Local Anesthesia without a Tourniquet for Non-Ischemic Contractures of the Forearm.

JBJS essential surgical techniques
2024

First report of Ageratum yellow vein virus infecting papaya in Lampung, Indonesia.

Molecular biology reports
2024

Novel loss-of-function variants expand ABCC9-related intellectual disability and myopathy syndrome.

Brain : a journal of neurology
2024

Medical comorbidities in patients with prolonged disorder of consciousness: A narrative review.

NeuroRehabilitation
2024

Generation of three induced pluripotent stem cell lines from individuals with Aicardi-Goutières syndrome caused by a c.3019G>A (p.G1007R) autosomal dominant pathogenic variant in ADAR1.

Stem cell research
2024

The Rogdi knockout mouse is a model for Kohlschütter-Tönz syndrome.

Scientific reports
2024

Novel Homozygous Variants of SLC13A5 Expand the Functional Heterogeneity of a Homogeneous Syndrome of Early Infantile Epileptic Encephalopathy.

Pediatric neurology
2023

Report and Abstracts of the 15th Congress of the Mediterranean Forum of Physical and Rehabilitation Medicine: Rome, July 6-8, 2023.

European journal of translational myology
2023

[The use of botulinum toxin type A in symptomatic therapy and medical rehabilitation of patients with multiple sclerosis].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2024

Bi-allelic ACBD6 variants lead to a neurodevelopmental syndrome with progressive and complex movement disorders.

Brain : a journal of neurology
2023

Methyl-CpG-Binding protein 2 duplication syndrome in a Chinese patient: A case report and review of the literature.

World journal of clinical cases
2023

Pathophysiology of cervical myelopathy (Review).

Biomedical reports
2024

Panoramic variation analysis of a family with neurodevelopmental disorders caused by biallelic loss-of-function variants in TMEM141, DDHD2, and LHFPL5.

Frontiers of medicine
2023

Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome.

Biology direct
2024

Identification of novel homozygous variants in FOXE3 and AP4M1 underlying congenital syndromic anophthalmia and microphthalmia.

The journal of gene medicine
2023

Towards Preclinical Validation of Arbaclofen (R-baclofen) Treatment for 16p11.2 Deletion Syndrome.

bioRxiv : the preprint server for biology
2023

SERAC1 Deficiency- A New Phenotype.

Endocrine, metabolic &amp; immune disorders drug targets
2024

Corticospinal tract: a new hope for the treatment of post-stroke spasticity.

Acta neurologica Belgica
2024

Intellectual Disability and Behavioral Deficits Linked to CYFIP1 Missense Variants Disrupting Actin Polymerization.

Biological psychiatry
2024

Epigenetic regulation of autophagy-related genes: Implications for neurodevelopmental disorders.

Autophagy
2023

A biallelic loss-of-function variant in TMEM147 causes profound intellectual disability and spasticity.

Neurogenetics
2023

Aicardi syndrome in a Nigerian female child: A case report and literature review of a rare neuro-developmental disorder from North-Western Nigeria.

Journal of the National Medical Association
2023

Tropical spastic paraparesis.

Handbook of clinical neurology
2023

Repetitive Sleep Starts in Allan-Herndon-Dudley Syndrome.

Pediatric neurology
2023

Biallelic MED27 variants lead to variable ponto-cerebello-lental degeneration with movement disorders.

Brain : a journal of neurology
2023

Occupational Therapy Intervention in the Child with Leukodystrophy: Case Report.

Children (Basel, Switzerland)
2023

Congenital heart defects in CTNNB1 syndrome: Raising clinical awareness.

Clinical genetics
2023

Juvenile Dermatomyositis and Infantile Cerebral Palsy: Aicardi-Gouteres Syndrome, Type 5, with a Novel Mutation in SAMHD1-A Case Report.

Biomedicines
2023

Untargeted Metabolomic Analysis of Sjögren-Larsson Syndrome Reveals a Distinctive Pattern of Multiple Disrupted Biochemical Pathways.

Metabolites
2024

Epileptic encephalopathy and amelogenesis imperfecta: What about KohlschüttereTönz syndrome? Case report and literature review.

Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
2023

Expanding the genetic spectrum of ALKU syndrome: Compound heterozygosity for two deleterious variants in SMG8 gene.

American journal of medical genetics. Part A
2023

Exome sequencing identifies a novel pathogenic variant in RAB3GAP1 causing Warburg Micro syndrome in a Pakistani family.

International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
2023

Adolescent/Adult-Onset Leukodystrophy with MTHFR Deficiency - A Treatable Cause.

Neurology India
2023

Early versus late injections of Botulinumtoxin type A in post-stroke spastic movement disorder: A literature review.

Toxicon : official journal of the International Society on Toxinology
2023

The Gross, Fine, and Oral Motor Functions in a Patient with Megalencephalic Leukoencephalopathy with Subcortical Cyst: A Case Report.

Iranian journal of child neurology
2023

Cation leak through the ATP1A3 pump causes spasticity and intellectual disability.

Brain : a journal of neurology
2023

Quantitative measures of motor development in Angelman syndrome.

American journal of medical genetics. Part A
2023

MECP2 duplication syndrome initially misdiagnosed as cerebral palsy: a case report.

The Journal of international medical research
2023

Sjögren-Larsson Syndrome: A Rare Presentation With Developmental Delay.

Cureus
2023

Adar-associated Aicardi Goutières syndrome in a child with bilateral striatal necrosis and recurrent episodes of transaminitis.

BMJ case reports
2023

Duplication within two regions distal to MECP2: clinical similarity with MECP2 duplication syndrome.

BMC medical genomics
2023

Novel, homozygous RAB3GAP1 c.2606 + 1G>A, p.Glu830ValfsTer9 variant and chromosome 3q29 duplication in a Turkish individual with Warburg micro syndrome.

Clinical dysmorphology
2023

The Mitochondrial tRNASer(UCN) Gene: A Novel m.7484A>G Mutation Associated with Mitochondrial Encephalomyopathy and Literature Review.

Life (Basel, Switzerland)
2023

Moyamoya syndrome secondary to mitochondrial disease in a patient with partial trisomy 13q14 and 13q31: A novel case report and literature review.

Heliyon
2023

Manifestations of Intellectual Disability, Dystonia, and Parkinson's Disease in an Adult Patient with ARX Gene Mutation c.558_560dup p.(Pro187dup).

Case reports in genetics
2023

Spasticity evaluation and management tools.

Muscle &amp; nerve
2023

TELO2-related syndrome (You-Hoover-Fong syndrome): Description of 14 new affected individuals and review of the literature.

American journal of medical genetics. Part A
2023

The clinical and genetic spectrum of autosomal-recessive TOR1A-related disorders.

Brain : a journal of neurology
2023

Ap4b1-knockout mouse model of hereditary spastic paraplegia type 47 displays motor dysfunction, aberrant brain morphology and ATG9A mislocalization.

Brain communications
2023

Establishment of a flow cytometry screening method for patients with glucose transporter 1 deficiency syndrome.

Molecular genetics and metabolism reports
2022

Pre- and Postnatal Characterization of Autosomal Recessive KIDINS220-Associated Ventriculomegaly.

Molecular syndromology
2023

Catatonia and Neuroleptic Malignant Syndrome in Patients With Cerebral Palsy: Two Case Reports and a Systematic Review of the Literature.

Journal of the Academy of Consultation-Liaison Psychiatry
2022

Whole-Exome Sequencing and Copy Number Analysis in a Patient with Warburg Micro Syndrome.

Genes
2022

Previously Undescribed Gross HACE1 Deletions as a Cause of Autosomal Recessive Spastic Paraplegia.

Genes
2023

Effects of L1 adhesion molecule agonistic mimetics on signal transduction in neuronal functions.

Biochemical and biophysical research communications
2022

Blended Phenotype of Prader-Willi Syndrome and HSP-SPG11 Caused by Maternal Uniparental Isodisomy.

Neurology. Genetics
2022

Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay due to Novel Mutations in the SACS Gene.

Journal of investigative medicine high impact case reports
2023

Putative founder effect of Arg338* AP4M1 (SPG50) variant causing severe intellectual disability, epilepsy and spastic paraplegia: Report of three families.

Clinical genetics
2023

Clinical and genetic analyses in syndromic intellectual disability with primary microcephaly reveal biallelic and de novo variants in patients with parental consanguinity.

Genes &amp; genomics
2022

TCEAL1 loss-of-function results in an X-linked dominant neurodevelopmental syndrome and drives the neurological disease trait in Xq22.2 deletions.

American journal of human genetics
2022

Bardet-Biedl Syndrome: A Rare Case From Ophthalmology Perspective.

Cureus
2022

Brazilian practice guidelines for stroke rehabilitation: Part II.

Arquivos de neuro-psiquiatria
2023

A Novel de novo KIF1A Mutation in a Patient with Ataxia, Intellectual Disability and Mild Foot Deformity.

Cerebellum (London, England)
2022

Spastic paraplegia 51: phenotypic spectrum related to novel homozygous AP4E1 mutation.

Journal of genetics
2022

An association study of IL2RA polymorphisms with cerebral palsy in a Chinese population.

BMC medical genomics
2022

Genetic and clinical characteristics of 24 mainland Chinese patients with CTNNB1 loss-of-function variants.

Molecular genetics &amp; genomic medicine
2022

Case report: Huppke-Brendel syndrome in an adult, mistaken for and treated as Wilson disease for 25 years.

Frontiers in neurology
2022

Early-Onset and Severe Complex Hereditary Spastic Paraplegia Caused by De Novo Variants in SPAST.

Movement disorders : official journal of the Movement Disorder Society
2022

Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants.

Genetics in medicine : official journal of the American College of Medical Genetics
2022

Multiple sclerosis and migraine: Links, management and implications.

Multiple sclerosis and related disorders
2022

Refractory status epilepticus with fever due to mumps vaccine-induced encephalitis caused secondary encephalopathy mimicking acute encephalopathy with biphasic seizures and late reduced diffusion.

Brain &amp; development
2022

AP-4 regulates neuronal lysosome composition, function, and transport via regulating export of critical lysosome receptor proteins at the trans-Golgi network.

Molecular biology of the cell
2022

[Nociceptive and mixed pains in patients with multiple sclerosis].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2022

Novel CTNNB1 variant leading to neurodevelopmental disorder with spastic diplegia and visual defects plus peripheral neuropathy: A case report.

American journal of medical genetics. Part A
2022

Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.

Qatar medical journal
2022

ASXL3 De Novo Variant-Related Neurodevelopmental Disorder Presenting as Dystonic Cerebral Palsy.

Neuropediatrics
2022

PSMC1 variant causes a novel neurological syndrome.

Clinical genetics
2022

Retinal Detachment Present at Birth in an Infant With a Novel CTNNB1 Mutation.

Ophthalmic surgery, lasers &amp; imaging retina
2022

Novel EPG5 Mutation Associated with Vici Syndrome Gene.

Case reports in genetics
2022

A homozygous Y443C variant in the RNPC3 is associated with severe syndromic congenital hypopituitarism and diffuse brain atrophy.

American journal of medical genetics. Part A
2022

Analysis of L1CAM gene mutation and imaging appearance in three Chinese families with L1 syndrome: Three case reports.

Molecular genetics &amp; genomic medicine
2022

Mutations in TAF8 cause a neurodegenerative disorder.

Brain : a journal of neurology
2022

[Restoration of hand function in patients with hemiparesis using mirror therapy in combination with myofascial stretching and postisometric relaxation].

Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury
2022

Quantitative Three-Dimensional Gait Evaluation in Patients With Glucose Transporter 1 Deficiency Syndrome.

Pediatric neurology
2022

An Observational Cross-Sectional Study of Gender and Disability as Determinants of Person-Centered Medicine in Botulinum Neurotoxin Treatment of Upper Motoneuron Syndrome.

Toxins
2022

An ultra-long new onset refractory status epilepticus: Winning the battle but losing the war?

Epilepsy &amp; behavior reports
2022

[Connotation of Baimai disease and analysis of compatibility and usage of Baimai Ointment: based on Tibetan medicine theory].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
2022

Molecular Characterization of Portuguese Patients with Hereditary Cerebellar Ataxia.

Cells
2022

Novel CAPN1 missense variants in complex hereditary spastic paraplegia with early-onset psychosis.

Annals of clinical and translational neurology
2022

Gait as a quantitative translational outcome measure in Angelman syndrome.

Autism research : official journal of the International Society for Autism Research
2022

Moyamoya syndrome in a young person with Down syndrome: diagnostic and therapeutic considerations.

BMJ case reports
2022

Motor and behavioral phenotype of Dravet syndrome in adulthood.

Epilepsy &amp; behavior : E&amp;B
2022

PRUNE1 c.933G>A synonymous variant induces exon 7 skipping, disrupts the DHHA2 domain, and leads to an atypical NMIHBA syndrome presentation: Case report and review of the literature.

American journal of medical genetics. Part A
2022

Molybdenum cofactor deficiency: A natural history.

Journal of inherited metabolic disease
2022

De Novo and Dominantly Inherited SPTAN1 Mutations Cause Spastic Paraplegia and Cerebellar Ataxia.

Movement disorders : official journal of the Movement Disorder Society
2022

Genetic diagnosis in Sudanese and Tunisian families with syndromic intellectual disability through exome sequencing.

Annals of human genetics
2022

De Novo ATP1A1 Variants in an Early-Onset Complex Neurodevelopmental Syndrome.

Neurology
2022

Bi-allelic variants in neuronal cell adhesion molecule cause a neurodevelopmental disorder characterized by developmental delay, hypotonia, neuropathy/spasticity.

American journal of human genetics
2022

Rhomboencephalosynapsis: Review of the Literature.

World neurosurgery
2022

L1 Syndrome Prenatal Diagnosis Supplemented by Functional Analysis of One L1CAM Gene Missense Variant.

Reproductive sciences (Thousand Oaks, Calif.)
2022

Intravenous ketogenic diet therapy for neonatal-onset pyruvate dehydrogenase complex deficiency.

Brain &amp; development
2021

[Clinical phenotype and genetic analysis of MECP2 duplication syndrome].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2021

Development and Internal Validation of a Disability Algorithm for Multiple Sclerosis in Administrative Data.

Frontiers in neurology
2022

A Diagnostic Approach to Spastic ataxia Syndromes.

Cerebellum (London, England)
2022

A novel homozygous synonymous variant further expands the phenotypic spectrum of POLR3A-related pathologies.

American journal of medical genetics. Part A
2021

Functions of the (pro)renin receptor (Atp6ap2) at molecular and system levels: pathological implications in hypertension, renal and brain development, inflammation, and fibrosis.

Pharmacological research
2021

Dysfunctional Homozygous VRK1-D263G Variant Impairs the Assembly of Cajal Bodies and DNA Damage Response in Hereditary Spastic Paraplegia.

Neurology. Genetics
2021

Electroclinical Features in MECP2 Duplication Syndrome: Pediatric Case Series.

Journal of child neurology
2022

Chédiak-Higashi syndrome presenting as a hereditary spastic paraplegia.

Journal of human genetics
2021

Intrathecal baclofen therapy for severe spasticity in an adult with tethered cord syndrome: a case report.

Journal of medical case reports
2021

Functional and Clinical Outcomes of Combined Simultaneous Bilateral Anterior Distal Femoral Plate Hemiepiphysiodesis and Hamstrings Release in Management of Knee Flexion Contractures in Children With Neuromuscular Disorders.

Journal of pediatric orthopedics
2021

Hip Displacement in MECP2 Disorders: Prevalence and Risk Factors.

Journal of pediatric orthopedics
2021

Re-analysis of whole-exome sequencing data reveals a novel splicing variant in the SLC2A1 in a patient with GLUT1 Deficiency Syndrome 1 accompanied by hemangioma: a case report.

BMC medical genomics
2022

Progressive encephalomyelitis with rigidity and myoclonus (PERM).

Practical neurology
2022

Delineating the genotypic and phenotypic spectrum of HECW2-related neurodevelopmental disorders.

Journal of medical genetics

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de paraplegia espástica-epilepsia-perturbação do desenvolvimento intelectual.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de paraplegia espástica-epilepsia-perturbação do desenvolvimento intelectual

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ainda não achamos doenças com sintomas parecidos o suficiente.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Expanding the Phenotypic Spectrum of the Recurrent De Novo FBXO31 p.Asp334Asn Variant: Evidence for a Novel Neurodevelopmental Disorder (Kruer Syndrome).
    Clinical genetics· 2026· PMID 41858232mais citado
  2. Multisystem manifestations of Sj&#xf6;gren-Larsson syndrome in early childhood and its dental implications.
    BMJ case reports· 2026· PMID 41825905mais citado
  3. CTNNB1-related disorders: clinical and radiological contributions from a French cohort.
    Frontiers in neurology· 2026· PMID 41789168mais citado
  4. Neuroradiological Phenotype Expansion of the Siddiqi Syndrome: A Case Report.
    Cellular and molecular neurobiology· 2026· PMID 41758270mais citado
  5. Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.
    American journal of human genetics· 2026· PMID 41720098mais citado
  6. Biallelic TTBK1 variant causes a severe syndromic neurodevelopmental disorder: clinical and genetic insights from two siblings.
    J Med Genet· 2026· PMID 41545183recente
  7. The first description of CTNNB1 syndrome in the Tunisian population: clinical investigation, molecular docking and molecular dynamics simulation of β-catenin/E-cadherin complex.
    Mol Biol Rep· 2025· PMID 41137963recente
  8. Gait abnormalities in children with FOXP1 syndrome: A case series.
    J Pediatr Rehabil Med· 2025· PMID 40521719recente
  9. New Insights Into TRMT10A Syndrome: Case Report and Literature Review.
    Am J Med Genet B Neuropsychiatr Genet· 2025· PMID 39440920recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2816(Orphanet)
  2. MONDO:0008439(MONDO)
  3. Epilepsia(PCDT · Ministério da Saúde)
  4. GARD:4915(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Q55345676(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de paraplegia espástica-epilepsia-perturbação do desenvolvimento intelectual
Compêndio · Raras BR

Síndrome de paraplegia espástica-epilepsia-perturbação do desenvolvimento intelectual

ORPHA:2816 · MONDO:0008439
🇧🇷 Brasil SUS
Geral
OMIM
182610
MedGen
UMLS
C1866854
Repurposing
14 candidatos
aminohydroxybutyric-acidcarbonic anhydrase inhibitor
diclofenamidesuccinimide antiepileptic
ethosuximideglutamate receptor antagonist
+11 outros
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades